THE DEVELOPMENT AND VALIDATION OF IMMUNOLOGICAL ASSAYS IN PATIENTS WITH PROSTATE CANCER

被引：0
|
作者：
Viney, R. P. C. [1 ]
Doherty, A. [1 ]
Gospar, P. [2 ]
Searle, P. F. [2 ]
机构：
[1] Queen Elizabeth Hosp, Dept Urol, Birmingham B15 2TH, W Midlands, England
[2] Univ Birmingham, Inst Canc Studies, Birmingham, W Midlands, England
来源：
EUROPEAN UROLOGY SUPPLEMENTS | 2010年 / 9卷 / 02期
关键词：
D O I：
10.1016/S1569-9056(10)60929-3
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：298 / 298
页数：1
相关论文
共 50 条
  • [31] Update: Immunological strategies for prostate cancer
    Drake C.G.
    Antonarakis E.S.
    Current Urology Reports, 2010, 11 (3) : 202 - 207
  • [32] Development and validation of a nomogram for predicting prostate cancer in patients with PSA ≤ 20 ng/mL at initial biopsy
    Wu, Qiang
    Li, Fanglong
    Yin, Xiaotao
    Gao, Jiangping
    Zhang, Xu
    MEDICINE, 2021, 100 (50) : E28196
  • [33] Development and External Validation of a Machine Learning Model for Prediction of Lymph Node Metastasis in Patients with Prostate Cancer
    Sabbagh, Ali
    Washington, Samuel L.
    Tilki, Derya
    Hong, Julian C.
    Feng, Jean
    Valdes, Gilmer
    Chen, Ming-Hui
    Wu, Jing
    Huland, Hartwig
    Graefen, Markus
    Wiegel, Thomas
    Boehmer, Dirk
    Cowan, Janet E.
    Cooperberg, Matthew
    Feng, Felix Y.
    Roach, Mack
    Trock, Bruce J.
    Partin, Alan W.
    V. D'Amico, Anthony
    Carroll, Peter R.
    Mohamad, Osama
    EUROPEAN UROLOGY ONCOLOGY, 2023, 6 (05): : 501 - 507
  • [34] Discovery and validation of prostate cancer biomarkers of biochemical recurrence in low-risk prostate cancer patients
    Kohaar, Indu
    Bejar, Kaitlyn
    Young, Denise
    Song, Yingjie
    Jiang, Jiji
    Kagan, Jacob
    Srivastava, Sudhir
    Hernandez, Javier
    Chesnut, Gregory
    Sesterhenn, Isabell A.
    Leach, Robin J.
    Petrovics, Gyorgy
    CANCER RESEARCH, 2022, 82 (12)
  • [35] Development of a novel protein biochip enabling validation of immunological assays and detection of serum IgG and IgM antibodies against Treponema pallidum pathogens in the patients with syphilis
    Huang, Na-Li
    Ye, Lei
    Schneider, Marion E.
    Du, Yi-Xin
    Xu, Yuan-Hong
    Fan, Li-Bin
    Du, Wei-Dong
    BIOSENSORS & BIOELECTRONICS, 2016, 75 : 465 - 471
  • [36] Development and validation of a UK-specific prostate cancer staging predictive model: UK prostate cancer tables
    Lam, Thomas B. L.
    Regnier-Coudert, Olivier
    McCall, John
    McClinton, Sam
    JOURNAL OF CLINICAL UROLOGY, 2012, 5 (05) : 224 - 235
  • [37] DETECTION OF PROSTATE-CANCER BY PROSTATE SPECIFIC ANTIGEN ASSAYS
    TOUBERT, ME
    SCHLAGETER, MH
    BRON, J
    TEILLAC, P
    LEDUC, A
    NAJEAN, Y
    PRESSE MEDICALE, 1990, 19 (24): : 1139 - 1142
  • [38] Development and validation of a predictive score for diagnosing prostate cancer in primary care
    Lapi, Francesco
    Marconi, Ettore
    Cricelli, Iacopo
    Sobrero, Alberto
    Salvetti, Andrea
    Campo, Salvatore
    Cricelli, Claudio
    JOURNAL OF EVALUATION IN CLINICAL PRACTICE, 2025, 31 (01)
  • [39] Development and validation of a polygenic hazard score for aggressive prostate cancer identification
    Mohamed, Nihal E.
    Tewari, Ashutosh K.
    Yadav, Kamlesh K.
    TRANSLATIONAL CANCER RESEARCH, 2019, 8 : S124 - S125
  • [40] Development and internal validation of preoperative transition zone prostate cancer nomogram
    Steuber, Thomas
    Chun, Felix K-H.
    Erbersdobler, Andreas
    Briganti, Alberto
    Haese, Alexander
    Graefen, Markus
    Schlomm, Thorsten
    Valiquette, Luc
    Huland, Hartwig
    Karakiewicz, Pierre I.
    UROLOGY, 2006, 68 (06) : 1295 - 1300
12345